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AmikacinAbstract The stem cells are widely used in the last few years in different ﬁelds of medicine, either
by external transplantation or endogenous mobilization, most of these studies are still experimental
on animals; few were tried on humans as in the spinal cord injury or myocardial infarction. As
regards its use in the inner ear, stem cell transplantation was examined in many previous studies,
while the mobilization idea is a new method to be experimented in inner ear hair cell regeneration.
The aim of this work was to assess the use of GCSF to induce bone marrow SC mobilization to
home and repair the damaged inner ear hair cells in rats after the damage had been inﬂicted by Ami-
kacin injection.
First we had to develop an animal model for damaged inner ear, so we used the well known oto-
toxic effect of Amikacin intra-tympanic injection till we reached complete loss of hearing function.
And this can be assessed by DPOAEs. Now we have an animal model of damaged inner ear hair cells
and mobilization of bone marrow SCs was induced by subcutaneous injection of G-CSF for 5 days.
Clinical assessment was done using DPOAEs before and after G-CSF injection also histological
assessment of the inner ear was done before and after G-CSF by two methods H&E staining and
Scanning Electron Microscopy.ed.
56 A.M. Elbana et al.The results of histological examination of the specimens showed some promising changes that
may be responsible for the improvement of hearing function in some rats that was detected by
OAEs.
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The inner ear is composed of two main parts. The auditory
portion includes the cochlea, which is involved in hearing,
and the vestibular system which is involved in balance. Our
ability to hear and our sense of balance are critically dependent
on specialized sensory receptors called hair cells, these cells
have structures called stereocilia, which sense sounds by bend-
ing back and forth, converting mechanical vibrations into elec-
trical, or neural signals that are then passed to the brain
through the auditory nerve.1,2
Auditory hair cells, like a microphone, are designed to con-
vert sounds into neural activity. Vestibular hair cells, those lo-
cated in structures called the semicircular canals; detect head
rotation, whereas other vestibular hair cells, located in struc-
tures called the utricle and saccule, sense head orientation with
respect to gravity.2,3
Finding ways to cure deafness represent a major scientiﬁc
and clinical breakthrough.1 Recently, stem cells from the inner
ear of adult mice have been identiﬁed.4 These adult stem cells
are found in the utricle of the vestibular region of the inner ear.
They have the characteristic features of stem cells such as the
capacity for self renewal and expansion (they divide and mul-
tiply). They form spheres, which begin to differentiate into new
cell types termed as progenitor cells. Some progenitor cells dif-
ferentiate into cells that express proteins and genes present in
the developing inner ear and nervous system. Under appropri-
ate conditions, some cells differentiate into cells resembling
hair cells, which have stereocilia; hair bundles protruding from
their surface and express speciﬁc hair cell marker proteins. The
discovery of such cells is a ﬁrst step toward a promising line of
treatment in restoring hearing and balance function.5,6
Stem cells are unspecialized cells that have two deﬁning
properties: the ability to differentiate into other cells and the
ability to self-regenerate. The ability to differentiate is the po-
tential to develop into other cell types. A totipotent stem cell
(e.g. fertilized egg) can develop into all cell types including
the embryonic membranes. A pluripotent stem cell can develop
into cells from all three germinal layers (e.g. cells from the in-
ner cell mass). Other cells can be oligopotent, bipotent or uni-
potent depending on their ability to develop into few, two or
one other cell type(s). Self-regeneration is the ability of stem
cells to divide and produce more stem cells.6,7
There are two main types of stem cells: embryonic and
adult stem cells. Embryonic stem cells are derived from em-
bryos. Typically 4 or 5 days old and consist of a hollow micro-
scopic collection of cells called the blastocyst. Unlike adult
stem cells, embryonic stem cells can become all cell types be-
cause they are pluripotent.8–11
Adult stem cells are stem cells that can be derived from dif-
ferent parts of the body and, depending on where they arefrom, have different properties. They exist in several different
tissues including the bone marrow, the blood and the brain.
Some studies have suggested that adult stem cells are very ver-
satile and can develop into many different cell types.12,13
Hematopoietic stem cells are adult stem cells found mainly
in the bone marrow and they provide the blood cells required
for daily blood turnover and for ﬁghting infections. Compared
to adult stem cells from other tissues, hematopoietic stem cells
are easy to obtain, as they can be either aspirated directly out
of the bone marrow or stimulated to move into the peripheral
blood stream, where they can be collected easily .14–19
More recently, their use in treatment of breast cancer and
coronary artery diseases has also been explored.20 The poten-
tial for hematopoietic stem cells to produce cell types other
than blood cells has become the subject of intense scientiﬁc
controversy, and it is still not clear whether they could be used
on a clinical scale to restore tissues and organs other than
blood and the immune system.21,22
Mesenchymal stem cells are another well-characterized
population of adult stem cells. These cells, also found in the
bone marrow, can form a variety of cells in the laboratory,
including fat cells, cartilage, bone, tendon and ligaments, mus-
cles cells, skin cells and even nerve cells. Unlike most other hu-
man adult stem cells, mesenchymal stem cells can be obtained
in quantities appropriate for clinical applications, making
them good candidates for use in tissue repair.16,23
From a scientiﬁc perspective, scientists will ﬁrst need to
identify compounds and conditions that can increase the
growth of stem cells and promote their differentiation into hair
cells or supporting cells.24 From a clinical perspective, surgical
and technical procedures need to be developed to successfully
transplant stem cells into the inner ear. The critical question to
be answered is whether transplanted stem cells can migrate to
the correct location, differentiate into hair cells and restore
hearing or balance.25,26
Mobilization of endogenous stem cells provides an alterna-
tive way of replacing damaged inner ear hair cells, and correct-
ing hearing loss.19,22 Mobilizing host stem cells is less
cumbersome than transplantation in that it avoids the logisti-
cal complexity associated with the use of embryonic as well as
non embryonic stem cells, including supply, surgical trauma,
and possibilities of graft rejection, uncontrolled graft cell pro-
liferation and tumor formation.
2. Aim
The aim of this work is to assess the use of G-CSF (Granulo-
cyte Colony Stimulating Factor) to mobilize Bone Marrow
Stem Cells to reach the inner ear of rats and its ability to repair
damaged inner ear after injecting Amikacin sulfate into the
middle ear of rats.
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3.1. Animals
 The study was carried out on 30 adult male rats of Sprague–
Dawley strain from the Medical Research Institute
experimental laboratory of the Veterinary Department of
Alexandria Medical School. The study was approved by
the medical ethics committee of Alexandria Faculty of
Medicine.
3.2. Drugs
 The procedure was done under general sedative anesthesia
using IM injection of Ketamine hydrochloride (50 lg/kg).
 Amikacin sulfate at starting dose of (5 lg/kg) was injected
intra-tympanic under microscopic magniﬁcation and
repeated until we reached complete cochlear damage.
 G-CSF (Granulocyte Colony Stimulating Factor) at a
dose of 200 lg/kg/day was injected subcutaneously for
5 days.
3.3. Instruments
 The intra-tympanic injection will be done under micro-
scopic magniﬁcation (Carl Zeiss laboratory microscope).
 Electrophysiological studies using the DPOAE (Distortion
product Otoacoustic Emission) will be used to assess
cochlear integrity before the start of procedure and after
injection of Amikacin sulfate to adjust the optimal dose
for complete cochlear damage. Then serial measurement
will be done after injecting G-CSF to assess any improve-
ment of cochlear function.
4. Methods
The study has been conducted on 30 adult male rats of Spra-
gue–Dawley strain from the Medical Research Institute exper-
imental laboratory of the Veterinary Department.
All rats were examined under microscopic magniﬁcation for
the tympanic membrane to exclude any ear abnormalities and
then subjected to DPOAEs to assess their cochlear integrity (to
ensure normal hearing before start of the trial). And the rats
which were deaf were excluded from the study.
Rats were randomly divided into two groups:
Group A consists of 15 rats which were dissected and the
inner ear was histologically examined as a negative control
for the other injected group.
Group B consists of 15 rats which were subjected to the
following:
(1) Intra-tympanic injection under microscopic magniﬁca-
tion with Amikacin sulfate at starting dose of 5 lg/kg
bilaterally in 10 rats and unilaterally in 5 rats.
(2) DPOAE of all injected rats (Group B) was done to
assess the hearing function after ﬁrst Amikacin
injection.
(3) Intra-tympanic Amikacin injection was repeated
until we had negative DPOAE of all injected rats(Group B) at 3, 6 and 9 weeks after ﬁrst Amikacin
injection.
(4) Subcutaneous injection of GCSF (Granulocyte Colony
Stimulating Factor) at a dose of 200 lg/kg/day for 5 suc-
cessive days for 10 rats of the 15 rats injected with Ami-
kacin (Group B).
The other 5 rats were kept untreated with GCSF as positive
control (hearing damaged by Amikacin but not treated with
GCSF).
(5) One month after GCSF treatment all rats were exam-
ined with DPOAEs to assess any improvement in the
hearing function and the same was repeated every
month till 6 months.
(6) Dissection of 2 rats was done every month one of
each group and the inner ear was histologically
examined.
(7) After the follow up period of 6 months, all the remaining
rats were dissected and the inner ear was histologically
examined.
Dissection was done as following:
1. Each rat was euthanized and decapitated and the skin
removed.
2. The head was cut into two halves by making an incision
at the midline.
3. The brain and brainstem were removed to expose the
temporal bone.
4. The petrous temporal part of the skull was trimmed and
sectioned longitudinally to expose the internal struc-
tures of the inner ear.
5. During dissection of specimens we kept them wet with
4% formaldehyde – 1% gluteraldehyde (4F-1G).
6. Specimens were labeled with rat numbers and sent for
histological examination.
Histological examination of the specimens was done as
following:
(1) Light microscopic examination of parafﬁn sections using
routine hematoxylin and eosin (H&E) stain.17
(2) Scanning electron microscopic examination of speci-
mens (SEM):
1. Fixation of specimen in 3% buffered gluteraldehyde
pH 7.3 for 2 h at 4 c followed by 4% formaldehyde
– 1% gluteraldehyde (4F-1G) for 48 h.
2. Washing in phosphate buffer for 15 min.
3. Post ﬁxation in freshly prepared 1% osmium tetraox-
ide in phosphate buffer at 4 c for 2 h with agitation.
4. Dehydration in ascending grades of acetone for
15 min.
5. Complete dehydration in isoamyl acetate for 15 min.
6. Critical point drying by liquid carbon dioxide at 40 c
at 1500 psi pressure.
7. Mounting on copper stubs and vacuum evaporation
with gold palladium ﬁlm layering.
8. Examination by Joel scanning electron microscope 5–
25 kV, Electron Microscopy Unit, Faculty of Science,
University of Alexandria.18
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The study has been conducted on 30 adult male rats of Spra-
gue–Dawley strain. They were randomly divided into two
groups: Group A consists of 15 rats not injected with Amika-
cin (ve Control). Group B consists of 15 rats which were all
injected intra-tympanic under Microscopic magniﬁcation with
Amikacin sulfate at a starting dose of 5 lg/kg, 5 rats were in-
jected unilaterally and 10 rats were injected bilaterally (see
Table 1).
After 3 weeks of ﬁrst Amikacin injection all injected rats
(Group B) were examined by DPOAE signals.Table 1 Distribution of rats at the start of the study.
No. %
Control rats (Group A) 15 50.0
Bilaterally injected rats 10 33.0
Unilaterally injected rats 5 17.0
Table 2 GCSF treatment.
5 rats of group B
5 rats of group B
N.B: one rat was dead from each group so we had 4 rats with unilateral
GCSF.
Table 3 6 months follow up on DPOAEs assessment according to
M1 M2 M3
No. % No. % No.
ve 8 100.0 8 100.0 6
+ve 0 0.0 0 0.0 2
p 1.000 0.157 0.083 0.046*
P: p value for McNemar test.
6 months follow up DPOAEs assessment according to Rats number.
* Statistically signiﬁcant at p 6 0.05.six rats of the 15 rats became deaf after 3 weeks of Amika-
cin injection, while the other 9 rats had a positive OAE and
still preserve residual hearing function. So intra-tympanic
Amikacin injection was repeated and waited another 3 weeks.
After 6 weeks of ﬁrst Amikacin injection all injected rats
(Group B) were examined again by DPOAEs.
Another 6 rats of the 15 rats became deaf 6 weeks after ﬁrst
Amikacin injection, while only 3 rats still had positive OAEs
and preserve residual hearing function. So intra-tympanic
Amikacin injection was repeated and waited another 3 weeks.
After 9 weeks of ﬁrst Amikacin injection all injected rats
(Group B) were examined again by DPOAEs and they were
all negative (complete loss of hearing function).
Subcutaneous injection of GCSF (Granulocyte Colony
Stimulating Factor) at a dose of 200 lg/kg/day for 5 successive
days was administered as shown in Table 2.
The other 5 rats of group B were bilaterally injected with
Amikacin and not treated with GCSF (Positive Control).
After one month of GCSF treatment all rats were examined
with DPOAEs to assess any improvement in the hearing func-
tion and the same was done every month till 6 months.Bilateral ear deafness induced by Amikacin and treated with GCSF
Unilateral ear deafness by Amikacin and treated with GCSF
ear deafness and 4 rats with bilateral ear deafness and treated with
rat numbers.
M4 M5 M6
% No. % No. % No. %
75.0 5 62.5 4 50.0 4 50.0
25.0 3 37.5 4 50.0 4 50.0
0.046*
Table 4 6 months follow up on DPOAEs assessment according to ear numbers.
M1 M2 M3 M4 M5 M6
No. % No. % No. % No. % No. % No. %
ve 12 100.0 12 100.0 10 83.3 9 75.0 7 58.3 7 58.3
+ve 0 0.0 0 0.0 2 16.7 3 25.0 5 41.7 5 41.7
p 1.000 0.157 0.083 0.025* 0.025*
P: p value for McNemar test.
6 months follow up DPOAEs assessment according to Ears Number.
6 months follow up DPOAEs assessment according to Ears Number. 
0
2
4
6
8
10
12
14
1 month 2 month 3 month 4 month 5 month 6 month
posive
negave
* Statistically signiﬁcant at p 6 0.05.
Figure 1 Control rat inner ear (normal rat). Light photomicro-
graphs of control rat inner ear cavity demonstrating the cochlear
cavity divided by the Reissener’s membrane (RM) into scala media
(SM) and scala vestibuli (SV). The organ of Corti (OC) intervenes
between the scala media and the scala tympani (ST). It is
boundered laterally by the stria vascularis (St V) and medially
by the spiral ganglion (SG). The semicircular duct (SD) shows the
macula utriculi (U) and the crista ampullaris (CA) (H&E stain.
Mic. Mag. ·40).
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In the ﬁrst 2 months after GCSF was given no improvement
could be detected in hearing with Oto-Acoustic Emissions.
In the third month we had 2 rats (2 ears one from the uni-
laterally injected group and the other ear from the bilaterally
injected group) which were negative OAEs became positive
OAEs.
In the fourth month we had 3 rats (3 ears one from the uni-
laterally injected group and two ears from the bilaterally injected
group) which were negative OAEs became positive OAEs.
In the ﬁfth month we had 4 rats (5 ears two from the uni-
laterally injected group and 3 ears from the bilaterally injected
group) which were negative OAEs became positive OAEs.
In the last month we had 4 rats (5 ears two from the unilat-
erally injected group and 3 ears from the bilaterally injected
group) which were negative OAEs became positive OAEs
(see Tables 3 and 4).
As regards rat numbers we noticed that in the ﬁrst 2 months
after GCSF treatment no improvement occurred (P= 1.000)
and in the third month there was improvement in 2 rats
(P= 0.157) and in the fourth month there was improvement
in 3 rats (P= 0.083) while in the ﬁfth and sixth month there
was improvement in 4 rats out of 8 rats injected with Amikacin
(P= 0.046).
As regards ear numbers we noticed that in the ﬁrst
2 months we had no improvement (P= 1.000) and in the third
month there was improvement in 2 ears (P= 0.157) and in the
fourth month there was improvement in 3 ears (P= 0.083)
while in the ﬁfth and sixth there was improvement in 5 ears
out of 12 ears injected with Amikacin (P= 0.025).5.2. Histological results
From the control group of rats we had an example of the nor-
mal inner ear as seen in light photomicrograph (Fig. 1) show-
ing the normal structural components of the cochlear duct and
the semicircular duct.
Figure 2a Control rat organ of Corti (normal rat). Light
photomicrographs of control rat Organ of Corti showing: the
main structural components including the spiral limbus (SL),
tectorial membrane (TM), inner supporting cells (IS), inner hair
cells (IHC), inner tunnel (IT), outer hair cells (OHC), outer
supporting cells (OS), basilar membrane (BM) and the related
cochlear nerve (CN) (H&E stain. Mic. Mag. ·400).
Figure 2b Higher magniﬁcation of the cellular components of
control rat organ of Corti demonstrating a single row of inner hair
cells (IHC) supported by the underlying inner phalangeal cells
(IPhC), and several rows of outer hair cells (OHC) supported by
the outer phalangeal cells (OPhC). The inner tunnel (IT) is
bounded between the inner (IP) and outer pillar (OP) cells (H&E
stain. Mic. Mag. ·1000).
Figure 3 Organ of Corti of rat injected with Amikacin. An OAE
negative rat (deaf), 6 months after administration of amikacin
revealing destruction of the organ of Corti (OC), disappearance of
the inner and outer supporting cells and inﬁltration of the cochlear
cavity by red blood corpuscles (arrow). Note the intact basilar
membrane (BM) (H&E stain. Mic. Mag. ·400).
Figure 4a Control rat stria vascularis. Light photomicrograph
of rat control stria vascularis shows an intact superﬁcial layer of
ﬂat epithelial cells (double arrows) and normal multiple intraep-
ithelial blood capillaries (single arrow) (H&E stain. Mic. Mag.
·400).
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·400) we can see the structures of normal Organ of Corti of
a control rat inner ear.
With further higher magniﬁcations (Mic. Mag. ·1000)
(Fig. 2b) we can see the cellular components of a normal Or-
gan of Corti of a control inner ear.
From the group injected with Amikacin we had an example
of light photomicrograph (Fig. 3) showing destruction of Or-
gan of Corti, disappearance of the inner and outer supporting
cells and inﬁltration of the cochlear cavity by red blood cells.
The stria vascularis of a normal control rat can be seen in
Fig. 4a with an intact superﬁcial layer of ﬂat epithelial cells
and normal multiple intraepithelial blood capillaries. And this
can be compared to the stria vascularis of an OAE negative rat
(deaf) 6 months after amikacin treatment (Fig. 4b) revealingfocal denudation of superﬁcial epithelium with vacuolation
and widening of stromal interstitial spaces.
The semicircular canal of a normal control rat inner ear
(Fig. 5a) and with higher magniﬁcation we can see the detailed
structure of normal crista ampullaris (Fig. 5b) and normal
macula utriculi (Fig. 5c) and this can be compared to the crista
ampullaris of an OAE negative rat (deaf) 6 month after amika-
cin treatment as seen in Fig. 6a which reveals vacuolation and
widening of interstitial spaces between hair and supporting
cells, but we noticed that many hair cells (HC) are still intact.
And also the macula utriculi in Fig. 6b shows intact layers of
hair and supporting cells and this indicates that the vestibular
structures are still intact or mildly affected after Amikacin
injection while its main effects were on the cochlear structures.
The spiral ganglion of a normal control rat inner ear that
can be seen in Fig. 7a demonstrates a closely packed group
of intact bipolar cells (BC) with normal eccentric nuclei and
prominent nucleoli. And this can be compared to the spiral
Figure 4b Stria vascularis of a rat injected with Amikacin. The
stria vasularis from an OAE negative (deaf) rat 6 month after
amikacin injection revealing focal denudation of superﬁcial
epithelium (double arrows) with vacuolation and widening of
stromal interstitial spaces (single arrow) (H&E stain. Mic. Mag.
·400).
Figure 5a Control rat semicircular duct. Light photomicrograph
of control rat semicircular duct (SD) lined by an intact membra-
nous labyrinth (ML) showing normal focal thickening to form the
macula utriculi (MU) and crista ampullaris (CA) (H&E stain. Mic.
Mag. ·100).
Figure 5b Control rat crista ampullaris. The crista ampullaris
shows an intact superﬁcial layer of hair cells (HC) supported by an
underlying layer of supporting cells (SC) and connective tissue
stroma (ct) (H&E stain. Mic. Mag. ·400).
Figure 5c Control rat macula utriculi. The macula utriculi shows
an intact superﬁcial layer of hair cells (HC) and the overlying
otoconia (O). It is supported by a deeper layer of supporting cells
(SC) and connective tissue stroma (ct) (H&E stain. Mic. Mag.
·400).
Figure 6a Crista ampullaris of a rat injected with Amikacin.
Light photomicrograph of OAE negative rat, 6 months after
injection with amikacin: the crista ampullaris reveals vacuolation
and widening of interstitial spaces between hair and supporting
cells (thick arrow). Note that many hair cells (HC) are still intact
(H&E stain. Mic. Mag. ·400).
Figure 6b Macula utriculi of a rat injected with Amikacin. The
macula utriculi shows intact layers of hair and supporting cells
(arrow) (H&E stain. Mic. Mag. ·400).
Endogenous bone marrow stem cell mobilization in rats: Its potential role in homing and repair of damaged inner ear 61
Figure 7a Control rat spiral ganglion. Light photomicrograph
of rat control spiral ganglion demonstrates a closely packed group
of intact bipolar cells (BC) with normal eccentric nuclei and
prominent nucleoli (thin arrow). Each cell is surrounded by
supporting satellite cells with ﬂat nuclei (thick arrow) (H&E stain.
Mic. Mag. ·400).
Figure 7b Spiral ganglion of a rat injected with Amikacin. The
spiral ganglion from an OAE negative (deaf) rat, 6 months after
injection with amikacin reveals loss of individual bipolar cells (*)
leaving empty spaces behind (H&E stain. Mic Mag. ·400).
Figure 8a Organ of Corti of rat recovering after GCSF regimen
after 4 weeks. Light photomicrographs of the organs of Corti of
OAE positive rats recovering within variable durations from
receiving GCSF therapeutic regimen: after 4 weeks, the organ of
Corti shows few outer hair cells (arrow). No other cellular
components of the organ of Corti are identiﬁable (H&E stain.
Mic. Mag. ·400).
Figure 8b Organ of Corti of rat recovering after GCSF regimen
after 8 weeks. After 8 weeks, the scala tympani reveals group of
cells (arrow) that are apparently organized into a primitive Organ
of Corti. Note that morphological identiﬁcation of individual hair
and supporting cells is not clear. SL = spiral limbus, BM= bas-
ilar membrane (H&E stain. Mic. Mag. ·400).
62 A.M. Elbana et al.ganglion of an OAE negative rat (deaf) 6 months after amika-
cin treatment as seen in Fig. 7b which reveals the loss of indi-
vidual bipolar cells leaving empty spaces behind.
From the group of rats treated with GCSF the histological
ﬁnding of an OAE positive rat recovering within variable dura-
tions after receiving GCSF therapeutic regimen can be demon-
strated as following:
After 4 weeks (Fig. 8a) the organ of Corti shows few outer
hair cells. No other cellular components of the organ of Corti
are identiﬁable.
After 8 weeks (Fig. 8b) the scala tympani reveals group of
cells that are apparently organized into a primitive Organ of
Corti, but morphological identiﬁcation of individual hair and
supporting cells is not yet clear.
After 12 weeks (Fig. 8c) the organ of Corti is formed of well
structured rows of inner supporting cells (IS), inner hair cells
(IH), outer hair cells (OH) and the intervening tunnels (T).
After 20 weeks (Fig. 8d) a fully structured Organ of Corti is
noticed with identiﬁable detailed cellular and structural
components.After 24 weeks (Fig. 9a) a fully structured organ of Corti is
noticed composed of intact rows of outer hair cells (OHC),
outer pillar cells (OP), an intact row of inner hair cells
(IHC), and inner pillar cells (IP). The outer (Oph) and inner
(Iph) phalangeal cells border the inner tunnel (IT). Also
(Fig. 9b) the stria vascularis reveals a complete sheet of intact
superﬁcial epithelium with residual interstitial vacuolation in
the supporting connective tissue stroma. Also intact macula
utriculi (Fig. 9c) and intact crista ampullaris (Fig. 9d) is no-
ticed. Also we can see intact spiral ganglion (Fig. 9e).
An example of a normal control rat organ of Corti can be
seen by scanning electron microscopy (Fig. 10a) demonstrating
normal hair cells (HC) with intact stereocilia projecting from
their apices. And with higher magniﬁcations (Fig. 10b) intact
stereocilia of hair cells (Fig. 10c) surface view of the reticular
Figure 8c Organ of Corti of rat recovering after GCSF regimen
after 12 weeks. After 12 weeks, the organ of Corti is formed of well
structured rows of inner supporting cells (IS), inner hair cells (IH),
outer hair cells (OH) and the intervening tunnels (T). SL = spiral
limbus, TM= tectorial membrane (H&E stain. Mic. Mag. ·400).
Figure 8d Organ of Corti of rat recovering after GCSF regimen
after 20 weeks. After 20 weeks, a fully structured Organ of Corti is
depicted with identiﬁable detailed cellular and structural compo-
nents. (IS) inner supporting cells, (OS) outer supporting cells, (IH)
inner hair cells, (OH) outer hair cells, (IP) inner pillar cells, (OP)
outer pillar cells, (TM) tectorial membrane, (RM) Reissener’s
membrane (H&E stain. Mic. Mag. ·400).
Figure 9a Organ of Corti of rat recovering after GCSF regimen
after 24 weeks. Light photomicrographs of the inner ear from
OAE positive rats recovering after 24 weeks from receiving GCSF
therapeutic regimen: showing a normal, fully structured organ of
Corti composed of intact rows of outer hair cells (OH), outer pillar
cells (OP) and an intact row of inner hair cells (IH) supported by
inner pillar cells (IP). The outer (Oph) and inner (Iph) phalangeal
cells border the inner tunnel (IT). (IS) inner supporting cells (H&E
stain. Mic Mag. ·400).
Figure 9b Stria vascularis of rat recovering after GCSF thera-
peutic regimen. The stria vascularis reveals a complete sheet of
intact superﬁcial epithelium (arrow) with residual interstitial
vacuolation in the supporting connective tissue stroma (*) (H&E
stain. Mic Mag. ·400).
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the outer hair cells were observed.
This can be compared to Scanning electron photomicro-
graphs of the inner ear in an OAE negative (deaf) rat,
6 months after treatment with amikacin (Fig. 11a) showing
the cochlear cavity is inﬁltrated by many red blood cells but
no details of hair cells neither of its stereocilia can be identiﬁed.
And with higher magniﬁcations (Fig. 11b) the surface view of
the reticular lamina (RL) of the organ of Corti showing paral-
lel rows of empty indentations marking the lost outer hair cells
was observed.
From the group of rats which have received GCSF we have
an example of scanning electron photomicrograph of the co-
chlear cavity of an OAE positive rat, recovering after 24 weeks
from receiving GCSF (Fig. 12) showing a group of intact hair
cells (HC) supported by the underlying phalangeal cells (Ph C)
and the hair cells show well formed apical stereocilia.6. Discussion
The use of stem cells in the repair of damaged inner ear was
ﬁrst tried by Ito et al. in 2001 using neural stem cells.19 And
also in 2003 they studied the fate of neural stem cells grafted
into injured inner ears of mice.20
In 2003 Li et al. have identiﬁed stem cells from the inner ear
of adult mice. These adult stem cells are found in the utricle of
the vestibular region of the inner ear.21 This discovery has
opened the door for many other researchers to explore the uti-
lization of stem cells in the inner ear repair and restoration of
hearing function.
Heller et al. in 2003 have studied the generation of hair cells
by stepwise differentiation of embryonic stem cells.22 And
Figure 9c Macula utriculi of rat recovering after GCSF thera-
peutic regimen. The macula utriculi shows intact structural
components: (HC) hair cells, (SC) supporting cells, (O) otoconia
(H&E stain. Mic Mag. ·400).
Figure 9d Crista ampullaris of rat recovering after GCSF
therapeutic regimen. The crista ampullaris shows intact layers of
hair cells (HC) and supporting cells (SC) (H&E stain. Mic Mag.
·400).
Figure 9e Spiral ganglion of rat recovering after GCSF thera-
peutic regimen. The spiral ganglion (arrow) is composed of intact
bipolar cells with apparently average cell density (H&E stain. Mic
Mag. ·100).
Figure 10a Control rat organ of Corti by scanning electron
microscopy (SEM). Scanning electron photomicrograph of con-
trol rat organ of Corti demonstrating: normal hair cells (HC) with
intact stereocilia (*) projecting from their apices (Mic. Mag.
·2000).
Figure 10b Control rat organ of Corti: surface view (SEM).
Intact stereocilia of hair cells (arrow) (Mic. Mag. ·2000).
Figure 10c Surface view of the reticular lamina (RL) showing
three parallel rows of intact stereocilia of the outer hair cells (Ph
C) bodies of supporting outer phalangeal cells (Mic. Mag. ·5000).
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Figure 11a Organ of Corti of a rat injected with Amikacin
(SEM). Scanning electron photomicrographs of the cochlear
cavity in an OAE negative (deaf) rat, 6 months after injecting
Amikacin: the cochlear cavity is inﬁltrated by many red blood cells
(arrow). No details of hair cells neither of its stereocilia can be
identiﬁed (Mic. Mag. ·1500).
Figure 11b Organ of Corti of a rat injected with Amikacin:
surface view (SEM). Surface view of the reticular lamina (RL) of
the organ of Corti showing parallel rows of empty indentations
(arrow) marking the lost outer hair cells (Mic. Mag. ·5000).
Figure 12 Organ of Corti of a rat recovering 24 weeks after
GCSF (SEM). Scanning electron photomicrograph of the cochlear
cavity of OAE positive rat, recovering after 24 weeks from
receiving GCSF. A group of intact hair cells (HC) is depicted.
The cells are supported by the underlying supporting phalangeal
cells (Ph C). Some hair cells show well formed apical stereocilia
(Mic. Mag. ·1500).
Endogenous bone marrow stem cell mobilization in rats: Its potential role in homing and repair of damaged inner ear 65Parker et al. in 2004 studied the potential use of stem cells for
cochlear repair.23 Also many other stem cell studies have been
done in the next few years between 2003 and 2010 but most of
these studies concentrated on the transplantation of stem cells
into the damaged inner ear or in vitro studies for generating
hair cells from stem cells of different origins.24–26
The idea of mobilization of bone marrow stem cells is new
and was proved to be successful in many other ﬁelds of medi-
cine, in 2006 Zohlnho¨fer et al. proved its use in acute myocar-
dial infarction to replace the damaged cardiomyocytes.27 Also
Kloner et al. tried its use on humans in 2006 in attempts to re-
cruit stem cells for repair of acute myocardial infarction.28
Mobilization of stem cells by GCSF was also utilized in
acute cerebral ischemia by Schabitz et al. in 2003 and by Shyu
et al. in 2006 in acute ischemic stroke.29,30
Also it was tried to use GCSF to mobilize bone marrow
stem cells in retinal damaged photoreceptors by Oishi et al.
in 2008 and in a model of Parkinson’s disease by Meuer
et al. in 2006 and in many other ﬁelds.31,32In this study rats were used as an animal model for the in-
ner ear study because they are the most commonly used animal
model for studying the drug effects on the inner ear due to sim-
ilarities between their inner ear anatomy and human inner ear
anatomy.19–21
At the beginning of the study we had to make sure of the
hearing ability of all rats because some genetic malformations
may exist in rats similar to humans which is not uncommon, so
we used Electrophysiological study which is a portable Oto-
acoustic emission (OAE) as a screening tool for hearing func-
tion and the rats which were negative were excluded before the
start of the study.
We used aminoglycosides (Amikacin sulfate) to cause co-
chlear damage to the rat’s inner ear because it have a more co-
chlear side effect than vestibular unlike Streptomycin and
Gentamicin which are the most commonly used drugs in the
past studies but their effect is more vestibular than cochlear.
Amikacin sulfate was injected via intra-tympanic approach
not via systemic approach to avoid its systemic nephrotoxic effect
which may have killed our rats before the follow up period of the
study, and also to allow rapid toxic effect on the inner ears. And
this was carried out under microscopic magniﬁcation.23,24
Amikacin injection was repeated until we had negative
OAEs of all injected rats and this was reached in all rats after
9 weeks of the ﬁrst Amikacin injection.
Some rats were injected with Amikacin bilaterally and oth-
ers were injected unilaterally, in the rats with unilateral injec-
tion the contralateral ears were used as a control to have the
same conditions and reduce the inter-animal variabilities.
We used a 5 day therapeutic regimen of subcutaneous injec-
tion of GCSF and the dose according to previous publications
in the literature in humans is 5–10 lg/kg/day but in rats it is
100–200 lg/kg/day.16
One month after GCSF treatment the rats were examined
with DPOAEs to assess any improvement in the hearing func-
tion and the same was done every month till 6 months.
After 6 month follow up we had 4 rats (5 ears) which were
negative OAEs became positive OAEs showing clinical
improvement in hearing function.
66 A.M. Elbana et al.The group which was bilaterally injected with Amikacin we had
2 rats (3 ears) improved after GCSF treatment after a total follow
up period of 6 month while in the group which was unilaterally in-
jected with Amikacin we had improvement in 2 rats (2 ears).
The positive control group (Rats which were bilaterally in-
jected with Amikacin but did not treated with GCSF) remains
negative OAEs after the same follow up period of 6 months
and this indicates that there was no spontaneous improvement
in hearing function over this period of time.
Histological comparison was done between the inner ear of
normal rats and the inner ear of Amikacin injected rats and
showed that the damage was more cochlear in the form of
destruction of Organ of Corti and disappearance of the inner
and outer supporting cells and hair cells.
After treating Amikacin injected rats with GCSF, histolog-
ical examination was done on variable durations and showed
improvement in the arrangement of hair cells till we reached
complete restoration of Organ of Corti after 6 months and this
was consistent with the clinical results of OAEs.
While histological examination of the positive control rats
(which were injected with Amikacin and not treated with
GCSF) showed no improvement and this was also consistent
with the clinical results.
7. Conclusions and future recommendations
The use of Stem cells in hearing loss correction is a widely
growing ﬁeld in the last few years.
 Stem cell mobilization is an alternative method for trans-
plantation in replacing damaged inner ear hair cells, and
correcting hearing loss that it avoids the logistical complex-
ity associated with the use of embryonic as well as non
embryonic stem cells, including supply, surgical trauma,
and possibilities of graft rejection, uncontrolled graft cell
proliferation and tumor formation.
 Aminoglycosides have an established ototoxic side effect,
Amikacin has a more cochlear effect than vestibular one
especially when injected intra-tympanic to avoid its sys-
temic effects.
 G-CSF is one of many other well known inducers for stem
cell mobilization from the bone marrow, and also it was
approved from the FDA to be used in humans in many
other ﬁelds like in myocardial infarction and cerebrovascu-
lar stroke.
 G-CSF can be used successfully in damaged inner ear hair
cells to induce stem cells mobilization from the bone mar-
row to home and reach the damaged organ which is the
inner ear in our case and it can result in some degree of hair
cell regeneration and hearing improvement.
 Hair cell regeneration can be assessed audiologically by
DPOAEs and histologically by microscopic examination
of inner ear organ of Corti.
 Future studies must utilize more animal models and over an
extended period of time.
 We also recommend the use of ABR to assess the hearing
function quantitatively better than the OAEs alone.
 A measure of stem cell mobilization is also recommended to
be used as blood analysis for stem cells.
 Detection of stem cells in the inner ear by immunohisto-
chemistry is recommended to be used.Disclosures
There are no disclosures to declare.
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